203 related articles for article (PubMed ID: 31415089)
1. Factors Associated With Diagnosis and Treatment of Thyroid Microcarcinomas.
Esfandiari NH; Hughes DT; Reyes-Gastelum D; Ward KC; Hamilton AS; Haymart MR
J Clin Endocrinol Metab; 2019 Dec; 104(12):6060-6068. PubMed ID: 31415089
[TBL] [Abstract][Full Text] [Related]
2. Thyroid Ultrasound and the Increase in Diagnosis of Low-Risk Thyroid Cancer.
Haymart MR; Banerjee M; Reyes-Gastelum D; Caoili E; Norton EC
J Clin Endocrinol Metab; 2019 Mar; 104(3):785-792. PubMed ID: 30329071
[TBL] [Abstract][Full Text] [Related]
3. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance.
Ho AS; Luu M; Zalt C; Morris LGT; Chen I; Melany M; Ali N; Patio C; Chen Y; Mallen St-Clair J; Braunstein GD; Sacks WL; Zumsteg ZS
Thyroid; 2019 Oct; 29(10):1409-1417. PubMed ID: 31407637
[No Abstract] [Full Text] [Related]
4. Papillary thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries.
Malandrino P; Pellegriti G; Attard M; Violi MA; Giordano C; Sciacca L; Regalbuto C; Squatrito S; Vigneri R
J Clin Endocrinol Metab; 2013 Apr; 98(4):1427-34. PubMed ID: 23482606
[TBL] [Abstract][Full Text] [Related]
5. Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.
Wallner LP; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Lubitz C; Hawley ST; Haymart MR
J Clin Endocrinol Metab; 2021 May; 106(6):e2402-e2412. PubMed ID: 33687063
[TBL] [Abstract][Full Text] [Related]
6. Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011.
O'Grady TJ; Gates MA; Boscoe FP
Int J Cancer; 2015 Dec; 137(11):2664-73. PubMed ID: 26069163
[TBL] [Abstract][Full Text] [Related]
7. Patient Report of Recurrent and Persistent Thyroid Cancer.
Papaleontiou M; Evron JM; Esfandiari NH; Reyes-Gastelum D; Ward KC; Hamilton AS; Worden F; Haymart MR
Thyroid; 2020 Sep; 30(9):1297-1305. PubMed ID: 32183609
[No Abstract] [Full Text] [Related]
8. Natural history of thyroid cancer [Review].
Takano T
Endocr J; 2017 Mar; 64(3):237-244. PubMed ID: 28154351
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and Treatment Patterns Among Children, Adolescents, and Young Adults with Thyroid Cancer in Ontario: 1992-2010.
Pole JD; Zuk AM; Wasserman JD
Thyroid; 2017 Aug; 27(8):1025-1033. PubMed ID: 28514192
[TBL] [Abstract][Full Text] [Related]
10. Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014.
Weeks KS; Kahl AR; Lynch CF; Charlton ME
Cancer; 2018 Apr; 124(7):1483-1491. PubMed ID: 29338082
[TBL] [Abstract][Full Text] [Related]
11. Understanding Pathways to the Diagnosis of Thyroid Cancer: Are There Ways We Can Reduce Over-Diagnosis?
Rahman ST; McLeod DSA; Pandeya N; Neale RE; Bain CJ; Baade P; Youl PH; Jordan SJ
Thyroid; 2019 Mar; 29(3):341-348. PubMed ID: 30700206
[TBL] [Abstract][Full Text] [Related]
12. The risk of second cancers after diagnosis of primary thyroid cancer is elevated in thyroid microcarcinomas.
Kim C; Bi X; Pan D; Chen Y; Carling T; Ma S; Udelsman R; Zhang Y
Thyroid; 2013 May; 23(5):575-82. PubMed ID: 23237308
[TBL] [Abstract][Full Text] [Related]
13. Predictors of incomplete response to therapy among Filipino patients with papillary thyroid cancer in a tertiary hospital.
Mendoza ES; Lopez AA; Valdez VA; Cunanan EC; Matawaran BJ; Kho SA; Sero-Gomez MH
J Endocrinol Invest; 2016 Jan; 39(1):55-62. PubMed ID: 26036600
[TBL] [Abstract][Full Text] [Related]
14. From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.
Jensen CB; Saucke MC; Francis DO; Voils CI; Pitt SC
Thyroid; 2020 May; 30(5):696-703. PubMed ID: 31910092
[No Abstract] [Full Text] [Related]
15. [Management of thyroid cancer in Spain].
Galofré JC
Endocrinol Nutr; 2010 Oct; 57(8):347-9. PubMed ID: 20801726
[No Abstract] [Full Text] [Related]
16. [Thyroid cancer screening: is it useful?].
Borson-Chazot F; Bournaud C
Presse Med; 2011 Dec; 40(12 Pt 1):1182-8. PubMed ID: 22104486
[TBL] [Abstract][Full Text] [Related]
17. Association of Socioeconomic Status and Race/Ethnicity With Treatment and Survival in Patients With Medullary Thyroid Cancer.
Roche AM; Fedewa SA; Chen AY
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):763-71. PubMed ID: 27254481
[TBL] [Abstract][Full Text] [Related]
18. Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes.
Hughes DT; Reyes-Gastelum D; Kovatch KJ; Hamilton AS; Ward KC; Haymart MR
Surgery; 2020 Jan; 167(1):102-109. PubMed ID: 31582311
[TBL] [Abstract][Full Text] [Related]
19. Adoption of Active Surveillance for Very Low-Risk Differentiated Thyroid Cancer in the United States: A National Survey.
Pitt SC; Yang N; Saucke MC; Marka N; Hanlon B; Long KL; McDow AD; Brito JP; Roman BR
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1728-e1737. PubMed ID: 33373458
[TBL] [Abstract][Full Text] [Related]
20. Physician Specialties Involved in Thyroid Cancer Diagnosis and Treatment: Implications for Improving Health Care Disparities.
Radhakrishnan A; Reyes-Gastelum D; Abrahamse P; Gay B; Hawley ST; Wallner LP; Chen DW; Hamilton AS; Ward KC; Haymart MR
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1096-e1105. PubMed ID: 34718629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
